Drug of Abuse Testing Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Drug of Abuse Testing Market Analysis
The drug abuse testing market is expected to register a CAGR of 7.5% over the forecast period (2022-2027).
COVID-19 had a significant impact on the growth of the market. According to the article titled "New trends of substance abuse during COVID-19 pandemic: An international perspective" published in July 2020, forced isolation and quarantine during COVID-19 can impact the behavior of drug abusers. Additionally, according to the Centers for Disease Control and Prevention (CDC), 2021, an individual with substance use disorder is expected to be severely ill or infected with the SARS-CoV2 virus. Also, as per the research data published in Population Health Management, 2021, a significant decrease in the testing for prescription and illicit drugs was observed, with a weekly test volume decrease of 70%. Hence, there was an increased need for healthcare and public health organizations to be involved in drug abuse testing during the pandemic era to minimize unfavorable health outcomes among the majority of the global population. Thus, COVID-19 had a significant impact on the growth of the market.
The drug abuse testing market is expected to observe good growth due to the increasing demand for drug abuse treatment, stringent laws mandating alcohol and drug testing, rising drug-related mortality, and increasing government initiatives.
The use of drugs was found to give rise to a lot of illegal activities that consume a lot of resources of a country. These aspects have driven the governments of developed and emerging nations to take legal action against addicts and abusers. Therefore, developed countries like the United States have stringent laws for drug abuse and have mandated alcohol and drug testing. To limit violence or accidents, drug and alcohol testing on the roads is becoming very common in developing and developed countries, which is helping the growth of the overall market. According to the data published by Organisation for Economic Co-operation and Development (OECD) published in 2020, almost one in third of adults in the European Union aged 15-64 or around 97 million people have used illicit drugs at some point in their lives, with the experience of drug use being more frequently reported by men than women. Thus, a growing trend witnessed in the drug abuse testing market is that leading players are enhancing their product portfolios by adding products and updating software with new substances for drug abuse testing to maintain their competency and market shares.
Identifying drug testing strategies is also necessary, as they may lead to the adoption of drug testing kits and devices and thus, boost the market growth. Other factors that are expected to positively affect the growth of this market include the increasing demand for drug addiction treatment, rising drug-related mortality, and growing government initiatives. This market is also currently growing due to technological advancements, increased sensitivity, minimal time required for testing, and facilitated detection of newly developed designer drugs. For instance, In April 2020, Cordant Health Solutions began a telemedicine-based oral fluid drug testing solution to assist in providing critical care to individuals recovering from substance use disorder.
Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period. However, the perception of Drug Abuse testing as a violation of rights is expected to limit the growth of the market.
Drug of Abuse Testing Market Trends
This section covers the major market trends shaping the Drug Abuse Testing Market according to our research experts:
The Urine Segment is Expected to Dominate in the Market Over the Forecast Period
Drug abuse testing by urine analysis has been suggested and implemented in many cases for workplace drug abuse, criminal justice cases, etc. There are many laboratory setups established to perform urinalysis associated with methadone treatment that has had to greatly expand their capacities. In recent years, many new laboratories have sprung up to meet the demands for drug assays, and clinical laboratories associated with medical centers, under economic pressures recent years, have begun to venture into drug testing. Therefore, the urine analysis segment of the market is expected to gain traction shortly.
Also, the technological developments in drug abuse testing, the increasing number of deaths due to drug overdose, and the growing demand for drug tests have led to the increasing use of urine analysis for drug abuse. Also, the advancements in guidelines by the providers are expected to boost the studied segment. For instance, with effect from April 2020, WellCare Health Plans introduced the new clinical coverage guidelines and claims payment policy for urine drug testing and included definitive urine drug testing as medically necessary as part of a routine monitoring program for individuals who receive treatment for chronic pain with prescription opioid or other potentially abused medications or those undergoing treatment for, or monitoring for relapse of, opioid addiction or substance use disorder.
Additionally, as per the article titled "Demand for interpretation of a urine drug testing panel reflects the changing landscape of clinical needs; opportunities for the laboratory to provide added clinical value " published in September 2020, there has been an increased adoption in the targeted panel of urine drug testing, and the value of clinical urine drug testing was observed to have improved by providing laboratory-based results interpretation and consultative services.
Thus, owing to the aforementioned factors, the studied segment is expected to witness healthy growth over the forecast period.
North America Holds the Large Market Share, and is Expected to do the Same Over the Forecast Period
North America accounts for the largest share of the drug abuse testing market globally. Drug abuse is a serious problem that can lead to legal, financial, and health problems, and the North American region is currently facing the same problems. Therefore, various initiatives are being implemented by the United States government to monitor the symptoms and to determine whether a person is under drug abuse. For instance, in October 2022, the Centers for Disease Control and Prevention (CDC) launched four education campaigns aimed at preventing drug overdose deaths.
There is also high adoption of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, and large-scale drug trafficking, which are all responsible for the growth of the market in the region. As per the data published by the Office of Disease Prevention and Health Promotion(ODPHP) in 2022, 14.2% of adolescents aged 12 to 17 years reported the use of alcohol or any illicit drugs. Additionally, in May 2020, Cannabix Technologies Inc. developed a new version of its THC Breath Analyzer, and it has been involved in developing the device for additional testing. Thus, the rising drug and alcohol abuse and emerging new technologies to detect intoxication in the body are expected to help the market growth in the region over the forecast period.
Thus the above-mentioned factors are expected to drive the growth of the market in this region during the forecast period.
Drug of Abuse Testing Industry Overview
The drug abuse testing market is moderately competitive. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. The major players in the drug abuse testing market include Danaher Corporation, Siemens Healthineers AG, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc., LabCorp, Abbott Laboratories, and Thermo Fisher Scientific Inc., among others.
Drug of Abuse Testing Market Leaders
-
Danaher Corporation (Beckman Coulter, Inc.)
-
Quest Diagnostics Inc.
-
LabCorp
-
Drägerwerk AG & Co. KGaA
-
Abbott Laboratories
*Disclaimer: Major Players sorted in no particular order
Drug of Abuse Testing Market News
- In August 2022, the Delaware Division of Public Health began including fentanyl strips in Narcan kits for distribution to the public. The effort was a part of a harm-reduction strategy aimed at preventing accidental overdoses due to fentanyl consumption.
- In June 2022, Punjab Government, India launched a drug screening drive in jails to detect drug abuse in jails. The screening of over 8,000 prisoners in over 14 jails has found that 42% of prisoners were drug addicts.
Drug of Abuse Testing Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Drug Abuse Treatment
4.2.2 Stringent Law Mandating Alcohol and Drug Testing
4.2.3 Rising Drug-related Mortality and Increasing Government Initiatives
4.3 Market Restraints
4.3.1 Perception of Drug Abuse Testing as a Violation of Rights
4.3.2 Lack of Awareness Regarding the Availability of Advanced Drug Testing Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Analyzers
5.1.1.1 Immunoassay Analyzers
5.1.1.2 Chromatographic Devices
5.1.1.3 Breath Analyzers
5.1.2 Rapid Testing Devices
5.1.2.1 Urine Testing Devices
5.1.2.2 Oral Fluid Testing Devices
5.1.3 Consumables
5.2 By Sample Type
5.2.1 Saliva
5.2.2 Urine
5.2.3 Blood
5.2.4 Other Sample Types
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostic Laboratories
5.3.3 Forensic Laboratories
5.3.4 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Danaher Corporation (Beckman Coulter)
6.1.3 LabCorp
6.1.4 Dragerwerk AG & Co. KGaA
6.1.5 Quest Diagnostics Inc.
6.1.6 Randox Testing Services
6.1.7 United States Drug Testing Laboratories Inc. (USDTL)
6.1.8 Thermo Fisher Scientific Inc.
6.1.9 Siemens Healthineers AG
6.1.10 F. Hoffmann-La Roche Ltd
6.1.11 Clinical Reference Laboratory Inc.
6.1.12 Cordant Health Solutions
6.1.13 Omega Laboratories Inc.
6.1.14 Psychemedics Corporation
6.1.15 Precision Diagnostics
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Drug of Abuse Testing Industry Segmentation
As per the scope of the report, drug abuse testing is found to be a clinical screening procedure to detect one or more illegal substances like drugs, chemicals, or plant products that patients are addicted to. This clinical screening procedure is performed on the patient's urine, saliva, blood, hair, or sweat. Today's modern lifestyle is pushing adults toward drug abuse, and to help them, the government is promoting DOA testing. The Drug Abuse Testing Market is Segmented by Product Type (Analyzers (Immunoassay Analyzers, Chromatographic Devices, and Breath Analyzers), Rapid Testing Devices (Urine Testing Devices and Oral Fluid Testing Devices), and Consumables), Sample Type (Saliva, Urine, Blood, and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD million) for the above segments.
| By Product Type | |||||
| |||||
| |||||
| Consumables |
| By Sample Type | |
| Saliva | |
| Urine | |
| Blood | |
| Other Sample Types |
| By End User | |
| Hospitals | |
| Diagnostic Laboratories | |
| Forensic Laboratories | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Drug of Abuse Testing Market Research FAQs
What is the current Global Drug Abuse Testing Market size?
The Global Drug Abuse Testing Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Global Drug Abuse Testing Market?
Danaher Corporation (Beckman Coulter, Inc.), Quest Diagnostics Inc., LabCorp, Drägerwerk AG & Co. KGaA and Abbott Laboratories are the major companies operating in the Global Drug Abuse Testing Market.
Which is the fastest growing region in Global Drug Abuse Testing Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Drug Abuse Testing Market?
In 2024, the North America accounts for the largest market share in Global Drug Abuse Testing Market.
What years does this Global Drug Abuse Testing Market cover?
The report covers the Global Drug Abuse Testing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Drug Abuse Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Drug of Abuse Testing Service Industry Report
Statistics for the 2024 Drug of Abuse Testing Service market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Drug of Abuse Testing Service analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
